Company Filing History:
Years Active: 2007-2019
Title: Innovations by Steven Pirie-Shepherd
Introduction
Steven Pirie-Shepherd is an accomplished inventor based in Cardiff, California. He has made significant contributions to the field of medical diagnostics and treatment through his innovative patents. With a total of two patents to his name, his work focuses on detecting and diagnosing specific types of cancer, as well as developing novel pharmaceutical compositions.
Latest Patents
Steven's latest patents include "Methods for detecting 5T4-positive circulating tumor cells" and "Methods of diagnosis of 5T4-positive cancer in a mammalian subject." These methods provide crucial techniques for identifying the presence of 5T4-positive metastatic cancer or early-stage 5T4-positive cancer in mammals. Additionally, he has developed a patent titled "Thiomolybdate analogues and uses thereof." This invention presents novel thiomolybdate derivatives and outlines methods for their production and application in treating diseases related to aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity, and NF-κB dysregulation.
Career Highlights
Throughout his career, Steven has worked with prominent companies such as Pfizer Corporation and Epic Sciences, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the medical field.
Collaborations
Steven has collaborated with notable professionals, including Hans-Peter Gerber and Dena Marrinucci. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work.
Conclusion
Steven Pirie-Shepherd is a notable inventor whose work in cancer detection and treatment exemplifies the importance of innovation in medicine. His patents reflect a commitment to advancing healthcare through scientific discovery and collaboration.